Clinical Trial

Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study

Completed
View on ClinicalTrials.gov →
Summary
This study assesses perceived usefulness of a web-based virtual prostate cancer genetics board for providers across academic, community, and veteran affairs settings to discuss prostate cancer genetics cases, precision treatment, and screening recommendation. Information gained from interviews and surveys of participants taking part in the virtual genetics board may lend insights into perceived usefulness, perceived ease of use, acceptability, self-efficacy, genetics knowledge, and barriers/facilitators to implementation to refine the process.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-15
notable Primary completion moved earlier: 2026-06-24 -> 2022-06-02 2026-08-15
minor Completion moved earlier: 2026-06-24 -> 2023-12-31 2026-08-15
Trial Details
NCT Number NCT04789018
Lead Sponsor Thomas Jefferson University
Conditions Prostate Carcinoma
Enrollment 118 participants
Start Date 2020-01-21
Primary Completion 2022-06-02 (estimated)
Study Completion 2023-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-14